Finance

Lists
ECOR:NASDAQ
electroCore, Inc.
$4.79
-1.03%
(-0.050) 1D
Nov 17, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ECOR...
Open
$4.84
High
$5.40
Low
$4.68
Mkt. cap
44.19M
Avg. vol.
127.86K
Volume
355.16K
52-wk high
$12.70
52-wk low
$4.37
EPS
-$1.39
Beta
1.23
Shares outstanding
9.23M
No. of employees
83
Open
$4.84
High
$5.40
Low
$4.68
Mkt. cap
44.19M
Avg. vol.
127.86K
Volume
355.16K
52-wk high
$12.70
52-wk low
$4.37
EPS
-$1.39
Beta
1.23
Shares outstanding
9.23M
No. of employees
83
News stories
From web sources and news partners
Profile
electroCore, Inc. is a medical technology company based in Basking Ridge, New Jersey. electroCore was co-founded in 2005 by JP Errico, Thomas J. Errico, MD, Charles Theofilos, MD, and Peter Staats, MD. The current chief executive officer is Daniel S. Goldberger. electroCore has one product called gammaCore, a non-invasive, commercially available product that uses vagus nerve stimulation. Wikipedia
About electroCore, Inc.
CEO-
Employees83
Founded2005
HeadquartersRockaway, New Jersey, United States
SectorHealth Care
IndustryMedical device
Analyst ratings
Based on 3 analysts giving stock ratings to ECOR in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ECOR in the last 3 months.
Highest
Current $4.79
$19.20 (+300.84%)
Average
$16.40 (+242.38%)
Lowest
$12.00 (+150.52%)
Analyst
Recommendation
Action
Price target
Projected
Date
Anthony Vendetti
Maxim Group
Buy
Reiterated
$12.00
+150.5%
11/06/2026
Swayampakula Ramakanth
H.C. Wainwright
Buy
Maintained
$18.00
+275.8%
11/06/2026
Jeffrey Cohen
Ladenburg Thalmann & Co.
Buy
Maintained
$19.20
+300.8%
11/05/2026
Matthew Keller
H.C. Wainwright
Buy
Reiterated
$18.00
+275.8%
09/21/2026
Ben Davis
RBC Capital
Buy
Reiterated
£185.00
+3,762.2%
06/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
9.24M
9.58M
9.45M
9.69M
Cost of goods sold
1.07M
1.22M
1.27M
1.12M
Cost of revenue
1.07M
1.22M
1.27M
1.12M
Research and development expenses
920.00K
740.00K
818.00K
431.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.19M
12.94M
10.13M
9.70M
Operating expense
11.11M
13.68M
10.95M
10.13M
Total operating expenses
12.18M
14.90M
12.22M
11.25M
Operating income
-2.94M
-5.32M
-2.77M
-1.56M
Other non operating income
714.00K
-10.00K
-6.00K
-4.00K
EBT including unusual items
-2.98M
-5.59M
-3.06M
-1.46M
EBT excluding unusual items
-2.47M
-5.59M
-3.06M
-1.46M
Income tax expense
51.00K
-321.00K
-
-126.00K
Effective tax rate
-1.71%
5.74%
-
8.60%
Other operating expenses
-
-
-
-
Net income
-3.04M
-5.27M
-3.06M
-1.34M
Net profit margin
-32.84%
-55.00%
-32.37%
-13.82%
Earnings per share
-
-
-
-
Interest and investment income
85.00K
52.00K
40.00K
465.00K
Interest expense
-324.00K
-318.00K
-321.00K
-370.00K
Net interest expenses
-239.00K
-266.00K
-281.00K
95.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.83M
-5.30M
-2.77M
-1.55M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps